Sanjiv K. Patel, M.D., is a distinguished leader in the biopharmaceutical industry, currently serving as the President and Chief Executive Officer at Relay Therapeutics Inc. Dr. Patel brings a wealth of experience and expertise to his role, having held various leadership positions in the life sciences sector. Prior to joining Relay Therapeutics, he was the President of Research and Development at TESARO, where he played a pivotal role in the company's growth and success. Under his leadership, TESARO developed and commercialized several innovative cancer therapies, significantly impacting patient care and outcomes. Dr. Patel's career is marked by a strong commitment to advancing medical science and improving patient lives. He has a proven track record of building high-performing teams and fostering a culture of innovation and excellence. His strategic vision and deep understanding of the drug development process have been instrumental in driving the success of Relay Therapeutics. At Relay, Dr. Patel oversees the company's mission to revolutionize drug discovery through the integration of cutting-edge computational and experimental approaches. His leadership has been crucial in advancing Relay's pipeline of promising oncology and genetic disease therapies. In addition to his professional achievements, Dr. Patel is a respected member of the scientific community, often contributing to industry discussions and thought leadership. He holds a Bachelor of Science degree from the Massachusetts Institute of Technology and a Doctor of Medicine from Harvard Medical School. His dedication to advancing healthcare and his ability to navigate the complexities of the biopharmaceutical industry make him an invaluable asset to Relay Therapeutics and the broader medical community.